AstaLynx Global Signs Multi-Year Contract with Biopharmaceutical for Drug Safety Technology Adoption and Implementation
NEW YORK, May 3, 2022 /PRNewswire/ -- AstaLynx Global today announced the agreement with a midsize biopharmaceutical company to centralize...